Antiplatelet therapy: Ticagrelor reduces cardiac events in patients with PAD or diabetes

Abstract

infarction (MI) and concomitant peripheral artery disease (PAD) or diabetes mellitus, addition of ticagrelor to standard aspirin therapy sig nificantly reduces major adverse cardiac events. These results were presented at the ACC.16 Scientific Sessions and simultaneously published in the Journal of the American College of Cardiology. Ticagrelor, a potent… (More)
DOI: 10.1038/nrcardio.2016.61

Topics

Cite this paper

@article{Huynh2016AntiplateletTT, title={Antiplatelet therapy: Ticagrelor reduces cardiac events in patients with PAD or diabetes}, author={Karina Huynh}, journal={Nature Reviews Cardiology}, year={2016}, volume={13}, pages={310-311} }